Cargando…
Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease
Development of therapeutics for the central nervous system is one of the most challenging areas in drug development. This is primarily because, in addition to all of the other complications one faces in developing new drugs targeting peripheral sites, one must also negotiate the blood-brain barrier...
Autor principal: | Banks, William A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604887/ https://www.ncbi.nlm.nih.gov/pubmed/19090999 http://dx.doi.org/10.1186/1471-2202-9-S3-S2 |
Ejemplares similares
-
Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
por: Pardridge, William M.
Publicado: (2020) -
Characteristics of compounds that cross the blood-brain barrier
por: Banks, William A
Publicado: (2009) -
The blood-brain barrier in Alzheimer's disease
por: Zenaro, Elena, et al.
Publicado: (2017) -
Blood–brain-barriers in aging and in Alzheimer’s disease
por: Marques, Fernanda, et al.
Publicado: (2013) -
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
por: Li, Jia, et al.
Publicado: (2021)